Our CEO, Dr. Shahid Shafi and his team at Baylor Scott & White Health made the cover of JAMA surgery – one of the top medical journals, with his publication on the opioid epidemic.
Here are the key points from his publication:
Question What are the incidence and consequences of opioid-related adverse drug events in patients undergoing hospital-based surgical and endoscopic procedures within a large, integrated health care delivery system?
Findings In this study of clinical and administrative data that included 135 379 patients, 14 386 (10.6%) experienced opioid-related adverse drug events. These events were associated with significantly worse patient outcomes, including increased inpatient mortality, greater likelihood of discharge to another care facility, prolonged length of stay, high cost of hospitalization, and higher rate of 30-day readmission.
Meaning Opioid-related adverse drug events occur commonly during episodes for hospital-based surgical and endoscopic procedures and are associated with worse patient outcomes.
You can find the full publication here.